M2698 free base · Synonyms: M-2698
M2698 is an orally active, ATP competitive, selective p70S6K and Akt dual-inhibitor.
For research use only. Not for human or veterinary use.
M2698 structure
CAS No.: 1379545-95-5
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 50 mg | USD 500.00 | BP-02489-50mg | In stock | Get quote |
| 100 mg | USD 800.00 | BP-02489-100mg | In stock | Get quote |
| 250 mg | USD 1,600.00 | BP-02489-250mg | In stock | Get quote |
| 500 mg | USD 2,560.00 | BP-02489-500mg | In stock | Get quote |
| 1 g | USD 4,100.00 | BP-02489-1g | In stock | Get quote |
| 2 g | Inquire | BP-02489-2g | In stock | Inquire |
| 3 g | USD 7,860.00 | BP-02489-3g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
M2698 (MSC2363318A) is an orally active, ATP competitive, selective p70S6K and Akt dual-inhibitor with IC50s of 1 nM for p70S6K, Akt1 and Akt3. M2698 can cross the blood-brain barrier and has anti-cancer activity .
Biological activity
In Vitro M2698 (0.3 nM to 50 M; 72 hours) inhibits proliferation in a dose-dependent manner in breast tumors cell lines with IC50s of 0.02-8.5 μM. ? M2698 (0.3, 1 μM; 24 hours) inhibits p70S6K activity and induces feedback loop phosphorylation on Akt and suppresses Akt activity in breast cancer cell lines. ? M2698 inhibits indirectly pGSK3β (IC50=17 nM) and pS6 (IC50=15 nM). In Vivo M2698 (10-30 mg/kg/day; PO; 28 days) results in dose-dependent inhibition of tumor growth and results in tumor regression with the highest dose of 30 mg/kg. ? M2698 (20 mg/kg/day; PO; 4 days) has a tumor:plasma exposure ratio of 12:1 over 24 hours and leads to increased levels of pAkt in tumor tissue. ? The mean total concentration of M2698 after 16-hour infusion in rats is 1750 ng/g and 175 ng/mL in brain and plasma, respectively. ? M2698 (po; 1, 5, 10, or 20 mg/kg/day; for 7 days) inhibits the phosphorylation of S6 in a dose-proportional manner over time after a single administration or daily treatments over 7 days.
Identifiers
- SMILES
-
NC(=O)C1=C2N=CN=C(N[C@H](CN3CCC3)C3=CC(=C(Cl)C=C3)C(F)(F)F)C2=CC=C1 - InChIKey
-
HXAUJHZZPCBFPN-QGZVFWFLSA-N
Specifications
- MW (average)
- 449.8570
- Formula
- C21H19ClF3N5O
- CAS No.
- 1379545-95-5
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20°C, protect from light, stored under nitrogen; In solvent -20°C, 1 year;
Solubility
Soluble in DMSO
Documents
References
Same target
Search Ribosomal S6 Kinase (RSK)- BP-01938 Clifutinib free base · >98%
- BP-02220 BAY1125976 free base · >98%
- BP-02268A Vevorisertib trihydrochloride salt · >98%
- BP-02280 AKT Kinase Inhibitor free base · >98%
- BP-02332 Afuresertib free base · >98%
- BP-02337 Lonafarnib free base · >98%
- BP-02343 Ipatasertib free base · >98%
- BP-02463 ASP3026 free base · >98%
Same research area
Search Cancer- BP-00001 KN-92 free base · >98%
- BP-00084 ORIC-944 free base · >98%
- BP-00104 BMS-986397 free base · >98%
- BP-00343 Opadotin free base · >98%
- BP-00752 CR-1-31-B free base · >98%
- BP-00756 PF-07853578 free base · >98%
- BP-00771A dTAGV-1 hydrochloride salt · >98%
- BP-00882 OPB-171775 free base · HPLC >98%, ee>98%